@article{TAU16853,
author = {Johannes Breyer},
title = {Improving outcome and prognosis prediction in non-muscle invasive bladder cancer using a gene expression score},
journal = {Translational Andrology and Urology},
volume = {6},
number = {5},
year = {2017},
keywords = {},
abstract = {Bladder cancer is the ninth most common malignancy worldwide considering both genders and approximately 75% of the patients are initially diagnosed with non-muscle invasive bladder cancer (NMIBC) (1,2). About 10–20% of the patients will suffer from progression to muscle-invasive disease (2-4). Due to long-term follow-up regimen with cystoscopies over many years, bladder cancer carries the highest cost among cancers per patient from diagnosis to death (5).},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/16853}
}